Navigation Links
Genesis Pharmaceuticals Affirms Operating Income Guidance, Adjusts Revenue Guidance for Fiscal 2009
Date:4/2/2009

LAIYANG, China, April 2 /PRNewswire-Asia-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today affirmed its previously announced operating income guidance of $40 to $43 million for its fiscal year ending June 30, 2009. The Company also adjusted its revenue guidance for its fiscal year ending June 30, 2009 from a range of $122 to $130 million to a range of $111 to $116 million as a result of restructuring how it distributes and sells its products.

The Company restructured its distribution and sales system to sell its Clarithromycin sustained-release tablets, Itopride Hydrochloride granules and Baobaole chewable tablets to hospitals and pharmacies through 28 large independent regional distributors. Each of these primary regional distributors works closely with sub-distributors and Genesis' internal marketing and sales network.

In connection with its sales restructuring, the Company lowered the per unit prices of certain products that the Company charges to regional distributors in cases where such regional distributors became responsible for some of the costs associated with these products that previously were direct marketing expenses of the Company. The Company adjusted its revenue guidance to reflect these adjusted prices.

The Company's new products, including Radix Isatidis dispersible tablets and products, acquired from its recent purchase of Hongrui Pharmaceuticals Company, will be sold through this new sales structure. However, the Company will not change its marketing method or sales structure with respect to the sale of its low margin Ciprofloxacin Hydrochloride tablets and Paracetamol tablets.

The Company works with regional distributors to design and jointly execute local marketing and promotional plans aimed
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Cardiogenesis Reports Fourth Quarter and Fiscal Year 2008 Results
2. New Directions in Angioedema: A Focus on Pathogenesis and Classification
3. Angiogenesis inhibitor improves brain tumor survival by reducing edema
4. CFO of Genesis Pharmaceuticals Gives Live Interview on Bloomberg TV Asia
5. Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st
6. Study sheds light on angiogenesis inhibitors, points to limitations, solutions
7. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
8. Genesis Successfully Defends Multi-Million Dollar Arbitration Filed by CRG and CRGP; Related Parties Withdraw Remaining Demands for Arbitration Against Genesis
9. Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
10. Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
11. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...A. Cook (GA), Louis J. Goodman (TX), Palmer P. Jon...GO, Nov. 7 The American...dical society executive leaders with achievement a...d ideals of the medical profession. The awards wer... meeting in Houston. ,, (Logo: http://www.ne...
(Date:11/7/2009)...ewswire/ -- With the final House vote on healthcar...g the entire bill hostage to further their antiabo...far beyond the status quo restrictions on abortion.... In an outrageous amendment, which is expected t... Democrats are demanding explicit and unequivocal ...
(Date:11/7/2009)...ewswire/ -- Speaker Nancy Pelosi and Democratic le...lowing a Democratic Whip meeting with President Ob...ker,s opening remarks: ,, "Thank you very much...o receive the President of the United States on th...e and making progress for the American people. ,...
(Date:11/7/2009)...ill rebel, expert says , , SATURDAY, Nov. ...ave badly if their parents expect them to, a new U...re simply being realistic might actually contribut..., a psychology professor at Wake Forest University...news release. "Negative expectations on the part o...
(Date:11/7/2009)...economic climate, many Americans are monitoring th...y on what that they consider to be absolutely esse...elieves that it’s very important for overwei...o improve their health, and he is trying to make w...tough economy by offering reasonable prices and mu...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3
... a stubborn myth, researchers at Johns Hopkins hav...nd other cerebrovascular diseases can safely// und...that many doctors have long shunned over concerns ...at not a single patient suffered complications dur...
...ins researchers have teased out the function of a ...rare cognitive disorder associated with overly soc...ed TFII-I, or TF “two eye,” the protein long known...study will be published this week in Science. ...
...y sufferers, the fall season can be just as bad as...ver-the-counter (OTC) medicine; however, can quick...ndividuals are faced with shelf after shelf of pro...t University of the Sciences in Philadelphia. “A l...
...and Fertiliser Minister Ram Vilas Paswan promises ...ee medicines, health insurance and subsidised trea...By Jan 1 we hope to have drug banks operational at...of the drug manufacturers who have agreed to provi...
... year, a National Academy of Sciences (NAS) panel ...ects of perchlorate, an inorganic anion and compon...s ability to absorb iodine from the bloodstream, b...archers at the Centers for Disease Control and Pre...
...hildren succumbing to dengue, the death toll from ... Pradesh.// 'A six-year-old child from Sitap...ward of King George's Medical University on Friday...mber of dengue cases has shot up to 199 in the sta...
Other Medicine News:Health News:Child-Proof: Brain Mapping Safer for Children than Previously Thought 2Health News:Child-Proof: Brain Mapping Safer for Children than Previously Thought 3Health News:Researchers Uncover Critical Player in Cell Communication 2Health News:Allergy OTC Medicines–Speak With Your Pharmacis 2Health News:Allergy OTC Medicines–Speak With Your Pharmacis 3Health News:Free Medicines, Health Insurance for Poor Soon: Paswan 2Health News:New Study Suggests Perchlorate Effects on Thyroid Function of U.S. Women 2
(Date:11/6/2009)...RNewswire-FirstCall/ -- Virtual Health Technologie... that the previously confirmed Letter of Intent to...gement Technologies, Inc (WNDM) is subject to fina...ders of VHGI. ,, Shareholder Assurances ,...royalty stream and cash realized from the transact...
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...wire/ -- California American Water has designated ... Drain" week for its San Diego County service area...c and private agencies alike toward the common mis...ource water supplies. ,, California American Wa... drop off expired or unwanted pharmaceuticals free...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2New oral agents may prevent injury after radiation exposure 51333 1New oral agents may prevent injury after radiation exposure 51333 2University of Hawaii at Manoa professor published in science journal 9207 1A complete view of complexity in science and society in a new authoritative reference work 9205 1A complete view of complexity in science and society in a new authoritative reference work 9205 2
...007 - AVANIR,Pharmaceuticals (NASDAQ:AVNR) today a...d improvements in patient-centered outcomes in,pat...ain treated,with the investigational drug Zenvia(T...d in two scientific posters at the,Second Internat...Berlin, Germany on June 7 to 10, 2007., Both poste...
...Results of a Phase 2a,clinical trial evaluating th...t hospital acquired gram-negative bacterial,pneumo...iety (ATS),International Conference, May 18 - 23, ... Niederman, MD, Chairman, Department of, ... of, Medicine; Vice Chairman, Department...
Other Medicine Technology:AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 4Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: